Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease.

Background: Treatment is indicated in dogs with preclinical degenerative mitral valve disease (DMVD) and cardiomegaly (stage B2). This is best diagnosed using echocardiography; however, relying upon this limits access to accurate diagnosis.

Objectives: To evaluate whether cardiac biomarker concentrations can be used alongside other clinical data to identify stage B2 dogs.

Percutaneous angiography of Patent Ductus Arteriosus in dogs: techniques, results and implications for intravascular occlusion.

Objectives: To evaluate the percutaneous angiography and the morphology of patent ductus arteriosus (PDA) in dogs.

Background: In contrast to surgical ligation the knowledge of angiographic morphology is necessary for intravascular PDA occlusion.

Methods: Forty-nine dogs with a left to right shunting PDA were included in a three-year, prospective study.

Gait analysis alters decision-making in cerebral palsy.

This study was designed to assess the impact of gait analysis on the treatment of patients with cerebral palsy. One hundred two ambulant patients with cerebral palsy were assessed clinically and with gait analysis. Separate treatment proposals for each patient were recorded after clinical examination and after gait analysis.